Results 221 to 230 of about 3,258,233 (341)
Food and Drug Administration, Partner in Drug Development
openaire +3 more sources
This study introduces a novel chitosan‐based nanocarrier functionalized with a neurotropic protein for efficient siRNA delivery to neurons. The polyplexes demonstrate enhanced neuronal binding, retrograde transport, and PTEN silencing, promoting axonal outgrowth.
Ana P. Spencer+10 more
wiley +1 more source
Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report. [PDF]
Bai JPF+10 more
europepmc +1 more source
AIMSPec‐LoC is a novel lab‐on‐a‐chip platform integrating size‐based extracellular vesicle (EVs) separation with label‐free Raman spectroscopy and AI‐powered classification via SKiNET. This high‐throughput, portable system enables real‐time, multiplexed molecular fingerprinting of EVs from biofluids, offering transformative potential for early, non ...
Emma Buchan+3 more
wiley +1 more source
A food and drug administration request for cooperation
Jeffrey D. Jones+3 more
openaire +2 more sources
Nanomaterial‐Enhanced Biosensing: Mechanisms and Emerging Applications
Nanomaterial integration transforms biosensor capabilities through enhanced signal transduction, sensitivity, and selectivity. This review analyzes how nanoscale materials—from nanoparticles to nanosheets—leverage unique physicochemical properties to revolutionize electrochemical, optical, and electrical biosensing.
Younghak Cho+3 more
wiley +1 more source
The limitations of existing clinical treatments highlight the need for a more comprehensive strategy for addressing infected diabetic wounds. A tri‐layered scaffold is developed to deliver therapeutics loaded in CuBDC and ZIF‐8 MOFs that are tailored to the requirements of deep‐infected diabetic wounds.
Ayse Gunyakti Mujtaba+8 more
wiley +1 more source
Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022. [PDF]
Zhang X+8 more
europepmc +1 more source
In this study, a novel cationic peptide, IW is designed and synthesized, with a tandem‐repeat sequence demonstrating potent activities against a broad spectrum of clinically relevant Carbapenem‐resistant Enterobacteriaceae in both the planktonic and biofilm states. IW is then formulated with P407 to form IW‐P407 colloids.
Ping Zeng+5 more
wiley +1 more source
Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database. [PDF]
Wang B+10 more
europepmc +1 more source